Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

NSCLC, Metastatic

ESMO-Congress-2023-Banner-1000x250px

Friday 20 October

Rethinking Cancer Therapies: Fresh Perspectives on MDM2-p53, HER2, DLL3 and Other Targets in Cancer

11-Rethinking-Cancer-Therapies-Fresh-Perspectives-BOEHRINGER-thumb

Friday, 18:00 - 19:30
View the satellite invitation

Saturday 21 October

Clinical Perspectives on the Evolution of NSCLC Treatment with I-O and ROS1 TKIs

15-Clinical-Perspectives-on-the-Evolution-of-NSCLC-Treatment-with-I-O-and-ROS1-TKIs-BMS-thumb

Saturday, 13:00 - 14:20
View the satellite invitation

Novel Targets in Advanced NSCLC: Leveraging Emerging Biomarkers in an Evolving Treatment Landscape

16-Novel-Targets-in-Advanced-NSCLC-Leveraging-Emerging-Biomarkers-SANOFI-thumb

Saturday, 13:00 - 14:30
View the satellite invitation

Millions of Lives. One Mission. Exploring the Potential of ADCs in Multiple Solid Tumours

20-Millions-of-Lives-One-Mission-Exploring-the-Potential-GILEAD-thumb

Saturday, 13:00 - 14:25
View the satellite invitation

Oncologists at the Helm of Translating Biomarker Insights into Actionable Patient Care

25-Oncologists-at-the-Helm-of-Translating-Biomarker-Insights-into-Actionable-Patient-Care-MSD-thumb

Saturday, 18:30 - 19:50
View the satellite invitation

Sunday 22 October

Transforming Treatment Approaches for Patients with EGFR-Mutant NSCLC

32-Transforming-Treatment-Approaches-for-Patients-with-EGFR-Mutant-NSCLC-JANSSEN-thumb

Sunday, 13:00 - 14:30
View the satellite invitation

Redefining Lung Cancer Together: A New Era for Patients

35-Redefining-Lung-Cancer-Together-A-New-Era-for-Patients-ROCHE-thumb

Sunday, 13:00 - 14:30
View the satellite invitation

ADCs’ Potential Across Tumors

38-ADCs-Potential-Across-Tumors-SEAGEN-Thumb

Sunday, 18:30 - 20:00
View the satellite invitation

The Multi-Tumor Toolkit: ADCs in Cancer Therapy

44-The-Multi-Tumor-Toolkit-ADCs-in-Cancer-Therapy-DAIICHI-SANKYO-thumb

Sunday, 18:30 - 20:00
View the satellite invitation

Monday 23 October

New Horizons in the Treatment of KRAS-Driven NSCLC and GI Cancers

46-New-Horizons-in-the-Treatment-of-KRAS-Driven-NSCLC-and-GI-Cancers-MIRATI-thumb

Monday, 13:00 - 14:30
View the satellite invitation

Considerations for Frontline Immunotherapy in NSCLC: A Case-Based Discussion

47-Considerations-for-Frontline-Immunotherapy-in-NSCLC-SANOFI-REGENERON-thumb

Monday, 13:00 - 14:30
View the satellite invitation

The Evolving Role of TTFields Therapy in Solid Tumors

51-The-Evolving-Role-of-TTFields-Therapy-in-Solid-Tumors-NOVOCURE-thumb

Monday, 13:00 - 14:30
View the satellite invitation

ALK+ NSCLC: Maximising the Potential for Patients throughout Their Treatment Journey

58-ALK+-NSCLC-Maximising-the-Potential-for-Patients-throughout-Their-Treatment-Journey-PFIZER-Thumb

Monday, 18:30 - 20:00
View the satellite invitation

Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.